Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 3.12 billion. The enterprise value is 3.03 billion.

Market Cap	3.12B
Enterprise Value	3.03B

Important Dates

The next estimated earnings date is Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	Apr 25, 2024

Share Statistics

Medistim ASA has 18.31 million shares outstanding. The number of shares has increased by 0.14% in one year.

Shares Outstanding	18.31M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.98%
Owned by Institutions (%)	58.14%
Float	15.51M

Valuation Ratios

The trailing PE ratio is 29.91 and the forward PE ratio is 27.03.

PE Ratio	29.91
Forward PE	27.03
PS Ratio	5.85
PB Ratio	8.15
P/FCF Ratio	27.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.83, with an EV/FCF ratio of 27.02.

EV / Earnings	29.00
EV / Sales	5.68
EV / EBITDA	19.83
EV / EBIT	23.44
EV / FCF	27.02

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 2.69.

Current Ratio	4.42
Quick Ratio	2.40
Debt / Equity	2.69
Debt / EBITDA	0.07
Debt / FCF	0.09
Interest Coverage	854.95

Financial Efficiency

Return on equity (ROE) is 28.31% and return on invested capital (ROIC) is 21.20%.

Return on Equity (ROE)	28.31%
Return on Assets (ROA)	17.56%
Return on Capital (ROIC)	21.20%
Revenue Per Employee	3.53M
Profits Per Employee	691,007
Employee Count	151
Asset Turnover	1.16
Inventory Turnover	0.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.51% in the last 52 weeks. The beta is 0.88, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	-26.51%
50-Day Moving Average	166.95
200-Day Moving Average	189.99
Relative Strength Index (RSI)	60.05
Average Volume (20 Days)	21,916

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 533.17 million and earned 104.34 million in profits. Earnings per share was 5.70.

Revenue	533.17M
Gross Profit	422.75M
Operating Income	129.10M
Pretax Income	135.31M
Net Income	104.34M
EBITDA	144.20M
EBIT	129.10M
Earnings Per Share (EPS)	5.70

Full Income Statement

Balance Sheet

The company has 107.06 million in cash and 10.32 million in debt, giving a net cash position of 96.74 million or 5.28 per share.

Cash & Cash Equivalents	107.06M
Total Debt	10.32M
Net Cash	96.74M
Net Cash Per Share	5.28
Equity (Book Value)	383.25M
Book Value Per Share	20.93
Working Capital	279.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 128.40 million and capital expenditures -16.40 million, giving a free cash flow of 112.00 million.

Operating Cash Flow	128.40M
Capital Expenditures	-16.40M
Free Cash Flow	112.00M
FCF Per Share	6.12

Full Cash Flow Statement

Margins

Gross margin is 79.29%, with operating and profit margins of 24.21% and 19.57%.

Gross Margin	79.29%
Operating Margin	24.21%
Pretax Margin	25.38%
Profit Margin	19.57%
EBITDA Margin	27.05%
EBIT Margin	24.21%
FCF Margin	21.01%

Dividends & Yields

This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 2.64%.

Dividend Per Share	4.50
Dividend Yield	2.64%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	9
Payout Ratio	78.76%
Buyback Yield	-0.14%
Shareholder Yield	2.50%
Earnings Yield	3.34%
FCF Yield	3.59%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a